Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05850416 · ClinicalTrials.gov registry record · NA
mGlide-Care: A Partnership With Caregivers
A NA study of HTN, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05850416 is a NA study of HTN that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05850416, a NA study of HTN, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypertension (HTN) is the most significant stroke, cardiovascular disease and dementia risk factor and is substantially under-treated especially in older persons. In this study the investigators will develop mGlide-Care to address uncontrolled HTN in people with mild cognitive impairment (MCI) and early stage Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD). mGlide-Care is adapted from mGlide which is a mHealth (mobile health technology) mediated care model for HTN care. Aim 1 will engage stakeholders to study the acceptability of mHealth mediated HTN care and will use their input to develop mGlide-Care. Stakeholders are persons with early stage AD/ADRD and MCI, unpaid family caregivers, primary care providers, geriatricians and clinical pharmacists. Aim 2 is a feasibility pilot to test mGlide-Care vs. usual care in 75 participants with uncontrolled HTN and early stage AD/ADRD or MCI. Caregivers will assist participants. Outcomes will include HTN control and participant and caregiver reported measures.
Conditions Studied
Interventions
- OTHER mGlide-Care
- OTHER Usual Care +
Study Locations (1)
Minnesota
- Epidemiology Clinical Research Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2028-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05850416
The ClinicalTrials.gov registry entry for NCT05850416 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HTN appearing as the primary indexed condition, and to 2 interventions - of which mGlide-Care is the first listed.
NCT05850416 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05850416 about?
NCT05850416 is a clinical study titled "mGlide-Care: A Partnership With Caregivers". Hypertension (HTN) is the most significant stroke, cardiovascular disease and dementia risk factor and is substantially under-treated especially in older persons. In this study the investigators will develop mGlide-Care to address uncontrolled HTN in people with mild cognitive impairment (MCI) and e...
What is the current status of trial NCT05850416?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-01-15. Estimated completion is 2028-05-30.
What conditions does trial NCT05850416 study?
This clinical trial studies the following conditions: HTN.
What interventions are being tested in trial NCT05850416?
The interventions under investigation include: mGlide-Care (OTHER), Usual Care + (OTHER).
Who is sponsoring clinical trial NCT05850416?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05850416 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.